Total Payments
$22,320
2024 Payments
$3,012
Companies
70
Transactions
1,428
Medicare Patients
4,621
Medicare Billing
$526,268
Payment Breakdown by Category
Food & Beverage$21,990 (98.5%)
Education$180.08 (0.8%)
Consulting$150.00 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,990 | 1,414 | 98.5% |
| Education | $180.08 | 13 | 0.8% |
| Consulting Fee | $150.00 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,399 | 182 | $0 (2024) |
| ABBVIE INC. | $2,180 | 124 | $0 (2024) |
| Novo Nordisk Inc | $1,991 | 137 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,675 | 129 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,547 | 105 | $0 (2024) |
| PFIZER INC. | $1,319 | 99 | $0 (2024) |
| Allergan, Inc. | $819.68 | 70 | $0 (2020) |
| Merck Sharp & Dohme LLC | $799.14 | 55 | $0 (2024) |
| Amgen Inc. | $715.33 | 39 | $0 (2024) |
| Astellas Pharma US Inc | $710.95 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,012 | 168 | ABBVIE INC. ($695.14) |
| 2023 | $3,170 | 193 | ABBVIE INC. ($634.11) |
| 2022 | $2,264 | 143 | ABBVIE INC. ($519.71) |
| 2021 | $2,509 | 158 | AbbVie Inc. ($330.55) |
| 2020 | $2,200 | 137 | AstraZeneca Pharmaceuticals LP ($468.67) |
| 2019 | $2,646 | 180 | AstraZeneca Pharmaceuticals LP ($561.98) |
| 2018 | $3,469 | 235 | AstraZeneca Pharmaceuticals LP ($529.65) |
| 2017 | $3,049 | 214 | AstraZeneca Pharmaceuticals LP ($714.14) |
All Payment Transactions
1,428 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: DIABETES | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: PAIN | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Obesity | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: Biological | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.04 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Cardio-renal | ||||||
| 11/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.99 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,007 | 1,877 | $359,150 | $112,929 |
| 2022 | 18 | 1,122 | 2,281 | $415,949 | $134,725 |
| 2021 | 17 | 1,148 | 2,016 | $337,182 | $125,648 |
| 2020 | 19 | 1,344 | 2,783 | $480,676 | $152,966 |
Total Patients
4,621
Total Services
8,957
Medicare Billing
$526,268
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 234 | 573 | $143,823 | $47,096 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 354 | $62,658 | $18,062 | 28.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 125 | 125 | $31,750 | $15,990 | 50.4% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 61 | 243 | $61,965 | $11,177 | 18.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 141 | 141 | $22,842 | $7,588 | 33.2% |
| 11045 | Removal of skin and tissue, each additional 20.0 sq cm or less | Office | 2023 | 20 | 136 | $11,139 | $2,718 | 24.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 129 | 129 | $4,644 | $2,361 | 50.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 120 | 120 | $4,320 | $2,196 | 50.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 14 | $5,614 | $2,012 | 35.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $6,820 | $1,928 | 28.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $3,575 | $1,800 | 50.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 248 | 655 | $165,060 | $56,807 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 145 | 424 | $75,896 | $22,735 | 30.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 124 | 124 | $31,868 | $16,401 | 51.5% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2022 | 61 | 252 | $65,520 | $11,742 | 17.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 126 | 126 | $20,916 | $7,041 | 33.7% |
| 11045 | Removal of skin and tissue, each additional 20.0 sq cm or less | Office | 2022 | 20 | 266 | $21,546 | $5,773 | 26.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 125 | 125 | $4,625 | $2,365 | 51.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 14 | $5,684 | $2,345 | 41.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 117 | 117 | $4,212 | $2,172 | 51.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $6,188 | $1,808 | 29.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 20 | 20 | $2,000 | $1,397 | 69.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 13 | $4,615 | $1,393 | 30.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 12 | 15 | $3,780 | $922.84 | 24.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 22 | 22 | $726.00 | $656.60 | 90.4% |
About Dr. Michael O'brien, MD
Dr. Michael O'brien, MD is a Family Medicine healthcare provider based in Reno, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2009. The National Provider Identifier (NPI) number assigned to this provider is 1598907453.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael O'brien, MD has received a total of $22,320 in payments from pharmaceutical and medical device companies, with $3,012 received in 2024. These payments were reported across 1,428 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($21,990).
As a Medicare-enrolled provider, O'brien has provided services to 4,621 Medicare beneficiaries, totaling 8,957 services with total Medicare billing of $526,268. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Reno, NV
- Active Since 03/24/2009
- Last Updated 05/08/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1598907453
Products in Payments
- FARXIGA (Drug) $2,496
- VRAYLAR (Drug) $1,429
- Ozempic (Drug) $1,087
- JARDIANCE (Drug) $951.35
- BREZTRI (Drug) $446.48
- Trintellix (Drug) $436.50
- UBRELVY (Drug) $392.64
- ELIQUIS (Drug) $390.60
- XIFAXAN (Drug) $389.25
- ANORO (Drug) $379.23
- NURTEC ODT (Drug) $377.94
- TRELEGY ELLIPTA (Drug) $368.59
- XARELTO (Drug) $341.20
- LINZESS (Drug) $330.68
- SHINGRIX (Biological) $328.43
- Rybelsus (Drug) $328.38
- Victoza (Drug) $310.47
- MYRBETRIQ (Drug) $305.92
- BEXSERO (Biological) $305.64
- QULIPTA (Drug) $301.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Reno
Catherine Mccarthy, Md, MD
Family Medicine — Payments: $52,895
Family Medicine $52,895
Dr. Jeremy Bearfield, Md, Phd, MD, PHD
Family Medicine — Payments: $22,339
Family Medicine $22,339
Dr. Vance Alm, Md, MD
Family Medicine — Payments: $18,168
Family Medicine $18,168
James Mclennan, Md Pc, MD PC
Family Medicine — Payments: $17,743
Family Medicine $17,743
Bayo Curry-Winchell, Md, MD
Family Medicine — Payments: $12,638
Family Medicine $12,638
Dr. Suraj Verma, M.d, M.D
Family Medicine — Payments: $12,462
Family Medicine $12,462